These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 26136051)
21. Targeting diverse protein-protein interaction interfaces with α/β-peptides derived from the Z-domain scaffold. Checco JW; Kreitler DF; Thomas NC; Belair DG; Rettko NJ; Murphy WL; Forest KT; Gellman SH Proc Natl Acad Sci U S A; 2015 Apr; 112(15):4552-7. PubMed ID: 25825775 [TBL] [Abstract][Full Text] [Related]
22. New helical foldamers: heterogeneous backbones with 1:2 and 2:1 alpha:beta-amino acid residue patterns. Schmitt MA; Choi SH; Guzei IA; Gellman SH J Am Chem Soc; 2006 Apr; 128(14):4538-9. PubMed ID: 16594667 [TBL] [Abstract][Full Text] [Related]
23. Crystallographic characterization of helical secondary structures in 2:1 and 1:2 alpha/beta-peptides. Choi SH; Guzei IA; Spencer LC; Gellman SH J Am Chem Soc; 2009 Mar; 131(8):2917-24. PubMed ID: 19203269 [TBL] [Abstract][Full Text] [Related]
24. Peptidomimetic therapeutic agents targeting the protease enzyme of the human immunodeficiency virus and hepatitis C virus. Tsantrizos YS Acc Chem Res; 2008 Oct; 41(10):1252-63. PubMed ID: 18681464 [TBL] [Abstract][Full Text] [Related]
25. Development and characterization of peptidic fusion inhibitors derived from HIV-1 gp41 with partial D-amino acid substitutions. Gaston F; Granados GC; Madurga S; Rabanal F; Lakhdar-Ghazal F; Giralt E; Bahraoui E ChemMedChem; 2009 Apr; 4(4):570-81. PubMed ID: 19206122 [TBL] [Abstract][Full Text] [Related]
26. Structural characterization of the feline-immunodeficiency-virus envelope glycoprotein 36 ectodomain for the development of new antivirals. Desmaris F; Lemaire D; Ricard-Blum S; Chatrenet B; Forest E Biochem J; 2005 Jul; 389(Pt 2):559-67. PubMed ID: 15799719 [TBL] [Abstract][Full Text] [Related]
27. Short-peptide fusion inhibitors with high potency against wild-type and enfuvirtide-resistant HIV-1. Chong H; Yao X; Qiu Z; Sun J; Zhang M; Waltersperger S; Wang M; Liu SL; Cui S; He Y FASEB J; 2013 Mar; 27(3):1203-13. PubMed ID: 23233535 [TBL] [Abstract][Full Text] [Related]
28. Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region. Eckert DM; Kim PS Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11187-92. PubMed ID: 11572974 [TBL] [Abstract][Full Text] [Related]
29. Quantitative understanding of pH- and salt-mediated conformational folding of histidine-containing, β-hairpin-like peptides, through single-molecule probing with protein nanopores. Mereuta L; Asandei A; Seo CH; Park Y; Luchian T ACS Appl Mater Interfaces; 2014 Aug; 6(15):13242-56. PubMed ID: 25069106 [TBL] [Abstract][Full Text] [Related]
31. Residue requirements for helical folding in short alpha/beta-peptides: crystallographic characterization of the 11-helix in an optimized sequence. Schmitt MA; Choi SH; Guzei IA; Gellman SH J Am Chem Soc; 2005 Sep; 127(38):13130-1. PubMed ID: 16173725 [TBL] [Abstract][Full Text] [Related]
32. Design of a peptide inhibitor that blocks the cell fusion mediated by glycoprotein 41 of human immunodeficiency virus type 1. Jin BS; Ryu JR; Ahn K; Yu YG AIDS Res Hum Retroviruses; 2000 Nov; 16(17):1797-804. PubMed ID: 11118065 [TBL] [Abstract][Full Text] [Related]
33. Conjugation of a nonspecific antiviral sapogenin with a specific HIV fusion inhibitor: a promising strategy for discovering new antiviral therapeutics. Wang C; Lu L; Na H; Li X; Wang Q; Jiang X; Xu X; Yu F; Zhang T; Li J; Zhang Z; Zheng B; Liang G; Cai L; Jiang S; Liu K J Med Chem; 2014 Sep; 57(17):7342-54. PubMed ID: 25156906 [TBL] [Abstract][Full Text] [Related]
34. Structure-activity relationships of anti-HIV-1 peptides with disulfide linkage between D- and L-cysteine at positions i and i+3, respectively, derived from HIV-1 gp41 C-peptide. Lee MK; Kim HK; Lee TY; Hahm KS; Kim KL Exp Mol Med; 2006 Feb; 38(1):18-26. PubMed ID: 16520549 [TBL] [Abstract][Full Text] [Related]
35. Membrane-perturbing domains of HIV type 1 glycoprotein 41. Mobley PW; Pilpa R; Brown C; Waring AJ; Gordon LM AIDS Res Hum Retroviruses; 2001 Mar; 17(4):311-27. PubMed ID: 11242518 [TBL] [Abstract][Full Text] [Related]
36. Foldameric α/β-peptide analogs of the β-sheet-forming antiangiogenic anginex: structure and bioactivity. Hegedüs Z; Wéber E; Kriston-Pál É; Makra I; Czibula Á; Monostori É; Martinek TA J Am Chem Soc; 2013 Nov; 135(44):16578-84. PubMed ID: 24088182 [TBL] [Abstract][Full Text] [Related]
38. Retrocyclin RC-101 overcomes cationic mutations on the heptad repeat 2 region of HIV-1 gp41. Fuhrman CA; Warren AD; Waring AJ; Dutz SM; Sharma S; Lehrer RI; Cole AL; Cole AM FEBS J; 2007 Dec; 274(24):6477-87. PubMed ID: 18028423 [TBL] [Abstract][Full Text] [Related]
39. Bcl-2 family proteins as targets for anticancer drug design. Huang Z Oncogene; 2000 Dec; 19(56):6627-31. PubMed ID: 11426648 [TBL] [Abstract][Full Text] [Related]
40. Stronger anti-HIV-1 activity of C-peptide derived from HIV-1 89.6 gp41 C-terminal heptad repeated sequence. Seo JK; Kim HK; Lee TY; Hahm KS; Kim KL; Lee MK Peptides; 2005 Nov; 26(11):2175-81. PubMed ID: 15876473 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]